“This is not a message of happiness or reassurance. But it is the truth.” — President Jimmy Carter, July 15, 1979

Since Americans began buying television sets, several commanders in chief have been given the title “TV president”: Richard Nixon, who faced John F. Kennedy in the first televised presidential debate and announced his resignation on air; Ronald Reagan, the former actor and “General Electric Theater” host; and Donald J. Trump, previously of “The Apprentice.”

Jimmy Carter, who died on Sunday at 100, is not one of the first leaders who come to mind in this way. But Mr. Carter was arguably the first president of TV’s full maturity. He served at the peak of the broadcast network monoculture, just before the spread of cable TV in the 1980s began to gradually split the audience into niche camps.

And he related to TV in a way that captured the 1970s essence of his presidency and his time.

Arriving post-Nixon and post-Vietnam — when Americans’ trust in authority was at a nadir — Mr. Carter offered a different image of national leadership. His was more approachable, humble, in sync with the dressed-down spirit of the ’70s and in tune with a national mood of soul-searching. He was a “Jimmy,” not a “James.”

That down-to-earth image was the anchor of one of the most famous portrayals of the president, by Dan Aykroyd on “Saturday Night Live.” (Mr. Carter was not the first president spoofed on “S.N.L.,” which began during the Ford administration, but he was the first elected during the show’s run.)

Mr. Aykroyd’s Carter, who spoke with a mellow Southern drawl, was a kind of people’s technocrat, a guidance counselor talking America through a weird phase. One of Mr. Aykroyd’s signature sketches, “Ask President Carter,” riffs on an actual radio call-in show that Mr. Carter hosted with Walter Cronkite in 1977. In the sketch, Mr. Aykroyd’s Carter walks a postal employee through a problem with a piece of machinery, then coolly talks down a teenage caller on a bad acid trip: “Just remember, you’re a living organism on this planet, and you’re very safe. You’ve just taken a heavy drug. Now relax, stay inside and listen to some music. Do you have any Allman Brothers?”

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.

Thank you for your patience while we verify access.

The W.H.O. had come under increasing criticism for declaring a global public health emergency for mpox last month without giving a vaccine that prequalification stamp of approval, or a more provisional form of approval called emergency use authorization. Bavarian Nordic first submitted its safety and effectiveness data on the vaccine, called Jynneos, to the W.H.O. in 2023. The W.H.O. had defended its slow pace of review, saying that it needed to subject the vaccine to careful study because it, and two others that have been used to protect against mpox, were originally designed as smallpox immunizations, and because delivering it in low-resource settings such as Central Africa would involve factors different from those relating to its use in high-income countries.

Already a subscriber? Log in.

Want all of The Times? Subscribe.sugarplay